MondegarAI
Madison Avenue Partners, LP

Q3 2024 · 13F-HR

Madison Avenue Partners, LPholdings as filed

Filed 2024-11-14 · accession 0001801265-24-000012

$1.08B
Reported value
25
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83444M101SOLVSOLVENTUM CORP$197.1M18.3%2,827,672CommonSOLE
384637104GHCGRAHAM HLDGS CO$193.3M17.9%235,271CommonSOLE
530307305LBRDKLIBERTY BROADBAND CORP$131.1M12.2%1,696,584CommonSOLE
968223206WLYWILEY JOHN & SONS INC$110.5M10.2%2,290,206CommonSOLE
379577208GMEDGLOBUS MED INC$81.3M7.54%1,137,050CommonSOLE
G8807B106TBPHTHERAVANCE BIOPHARMA INC$76.7M7.11%9,511,150CommonSOLE
85256A109STGWSTAGWELL INC$50.2M4.65%7,147,662CommonSOLE
219798105QDELQUIDELORTHO CORP$47.1M4.37%1,033,382CommonSOLE
G4766E116INDVINDIVIOR PLC$38.6M3.58%3,960,772CommonSOLE
64031N108NNINELNET INC$32.9M3.05%290,213CommonSOLE
264147109DCODUCOMMUN INC DEL$23.9M2.22%363,729CommonSOLE
29260Y1090C3ENDEAVOR GROUP HLDGS INC$20.9M1.93%730,260CommonSOLE
457651107INVXINNOVEX INTERNATIONAL INC$15.0M1.39%1,024,467CommonSOLE
901384107TSVT*2SEVENTY BIO INC$12.1M1.12%2,563,222CommonSOLE
65249B109NWSANEWS CORP NEW$11.4M1.06%428,040CommonSOLE
023939101AMTMAMENTUM HOLDINGS INC$11.1M1.03%383,218CommonSOLE
761330109RVNCEURREVANCE THERAPEUTICS INC$7.0M0.65%1,353,321CommonSOLE
35471R106FSPFRANKLIN STR PPTYS CORP$5.8M0.54%3,291,443CommonSOLE
690469101OVIDOVID THERAPEUTICS INC$4.9M0.45%4,116,773CommonSOLE
60783X104MODVQMODIVCARE INC$3.7M0.35%261,511CommonSOLE
65249B208NWSNEWS CORP NEW$1.5M0.14%52,534CommonSOLE
153436100CEECENTRAL & EASTERN EUROPE FD$851,1680.08%79,400CommonSOLE
G8068L108SNSHARKNINJA INC$668,7840.06%6,152CommonSOLE
87427V103TALKTALKSPACE INC$537,6280.05%257,238CommonSOLE
98888T107ZIMVZIMVIE INC$28,1060.00%1,771CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.